A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
Our main goal is to offer all women in the world, in addition to the treatment of vaginal atrophy, the benefits of effective, physiological and non-negative treatments for all menopausal problems, including hot flashes, sexual dysfunction, bone loss and muscle loss.
Quebec City, January 17, 2019 – It is with great sadness that Endoceutics management announces the death of its president and founder Dr. Fernand Labrie at the age of 81.
